STOCK TITAN

Intra-Cellular Therapies to Present at the Canaccord Genuity 43rd Annual Growth Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) announced its participation at the Canaccord Genuity 43rd Annual Growth Conference on August 9, 2023, at 1:30 p.m. ET. The company will present its developments in therapeutics for central nervous system disorders. The live and archived webcast can be accessed on the company's website.
Positive
  • None.
Negative
  • None.

NEW YORK, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that it will present at the Canaccord Genuity 43rd Annual Growth Conference on Wednesday, August 9, 2023 at 1:30 p.m. ET.

The live and archived webcast can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.

About Intra-Cellular Therapies

Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. For more information, please visit www.intracellulartherapies.com.

Contact:

Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D.
Vice President, Corporate Communications and Investor Relations
646-440-9333

Burns McClellan, Inc.
Cameron Radinovic
cradinovic@burnsmc.com
212-213-0006


FAQ

What is the event Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) will participate in?

The company will present at the Canaccord Genuity 43rd Annual Growth Conference on August 9, 2023, at 1:30 p.m. ET.

What is the focus of Intra-Cellular Therapies, Inc. (Nasdaq: ITCI)?

The company is focused on the development and commercialization of therapeutics for central nervous system disorders.

Where can the webcast be accessed?

The live and archived webcast can be accessed on the company's website under 'Events & Presentations' in the Investor Relations section.

Intra-Cellular Therapies Inc.

NASDAQ:ITCI

ITCI Rankings

ITCI Latest News

ITCI Stock Data

9.08B
101.92M
2.33%
96.02%
2.23%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
BEDMINSTER